We report the response to risperidone in seven hospitalized, adult pat
ients who presented psychotic symptoms etiologically related to a gene
ral medical condition. The conditions included brain surgery in two, a
nd anticardiolipin syndrome, renal failure, epilepsy, lupus, and metas
tatic carcinoma in one each. Four patients had failed previous treatme
nt with at least one typical antipsychotic agent. Response to risperid
one was assessed by the Brief Psychiatric Rating Scale (BPRS). Serum w
as collected for measurement of steady-stale trough risperidone and 9-
hydroxyrisperidone concentrations at effective doses in three patients
. Amelioration of psychotic symptoms was noted in all seven patients.
Mean (+/-SD) BPRS scores were reduced significantly from baseline (63.
0 +/- 15.1) to endpoint (27.0 +/- 3.5; p < 0.01). The mean effective d
aily dose of risperidone was 3.1 +/- 1.7 mg and rime to response was 4
.7 +/- 2.4 clays. Risperidone was not present at detectable concentrat
ions in the three patients studied. The mean steady-state trough serum
concentration of 9-hydroxyrisperidone in the three patients assessed
was 20.3 +/- 9.8 ng/ml. These preliminary findings, which suggest that
risperidone is a safe and effective agent in patients with psychotic
symptoms due to various medical conditions, need to be confirmed by ra
ndomized, antipsychotic comparison trials involving a larger number of
patients. (C) 1997 by Elsevier Science Inc.